Press Release: EU-wide recall of Raptiva (efalizumab) to be initiated

The European Medicines Agency (EMEA), in June 2009, agreed to an EU-wide recall of the remaining batches of Raptiva, from Merck Serono. Following the recall, the medicine will no longer be available anywhere in the European Union.

• Primary Source

EMEA: Public statement on Raptiva (efalizumab), 3.8.09 http://www.emea.europa.eu/humandocs/PDFs/EPAR/raptiva/48710709en.pdf

---